Saint Joseph’s Medical Center in Yonkers announces the opening of the Center for Wound Care and Hyperbaric Medicine, an outpatient facility offering a comprehensive approach for patients with nonhealing wounds.
The Center for Wound Care and Hyperbaric Medicine at Saint Joseph’s Medical Center is open Monday through Friday, 8 a.m. to 4:30 p.m., at 127 S. Broadway in Yonkers. Information is also available at saintjosephs.org.
Seven employees at Westchester Medical Center and Maria Fareri Children’s Hospital were the first to graduate from a new workforce development program made possible through a $100,000 grant from the KeyBank Foundation. The program is designed to help employees move up the career ladder in the healthcare field.
From left: School at Work instructors Kassime Berthe, Victoria Leitner and Loren Bartley; and graduates Sihara Villanueva, Julia Esprit, Alemni DeJesus, Tameka Dawson, Urcella Brown, Minerva Boyd and Francis Acheampong
Current entry-level employees recently completed an eight-month, 12-module program to provide them with the skills needed to advance in healthcare careers. Course topics include mastering communication, patient safety and satisfaction, medical terminology, and planning, among others.
The graduates plan to pursue careers as social workers, ultrasound technicians, information technology and human resources staff, surgical technicians, and registered nurses.
Once again, the Elizabeth Seton Pediatric Center was recognized for its delivery of exceptional patient care with a deficiency-free rating from the New York State Department of Health (DOH) during its annual, unannounced Centers for Medicare & Medicaid Services (CMS) Long Term Care Survey.
This is Elizabeth Seton Pediatric Center’s eighth deficiency-free survey since 2004 and the fourth since moving to its new facility in March 2012.
“The CMS Long Term Care Survey is a newly implemented survey process, which incorporates the most significant federal nursing home regulatory reform in the nation’s history, called the Mega Rule,” says Lisa Poskanzer, Vice President of Operations at the Pediatric Center. “New clinical pathways, resident and family interviews, and observation protocols were integrated.”
NewYork-Presbyterian Lawrence Hospital has earned The Joint Commission’s Gold Seal of Approval for Bariatric Surgery Certification. The Gold Seal of Approval is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.
Established in 2002 and awarded for a two-year period, The Joint Commission’s Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas:
- Compliance with consensus-based national standards
- Effective use of evidence-based clinical practice guidelines to manage and optimize care
- An organized approach to performance measurement and improvement activities.
Montefiore Health System and Crystal Run Healthcare have finalized details of a formal relationship effective Jan. 1, 2018. Crystal Run Health Transformation Holdings LLC (CRHT), a new entity — neither a merger nor acquisition — will be operated collaboratively by Crystal Run and Montefiore. CRHT will oversee, direct and allocate the resources required to execute on the shared mission and vision of Crystal Run and Montefiore: to be the healthcare provider of choice for the Hudson Valley.
The relationship establishes the sharing of clinical best practices, care management expertise and information technology platforms between the organizations to advance Crystal Run’s and Montefiore’s efforts to achieve the triple aim of healthcare transformation — better health, better health care and lower cost for patients. The relationship will increase access to Crystal Run Health Plans, Crystal Run’s health insurance and HMO products, in the Hudson Valley. The new relationship will also enhance educational opportunities for medical students at Albert Einstein College of Medicine and physician trainees at Montefiore, and will create teaching and learning opportunities for Crystal Run physicians.
Researchers at Pace University, Queens College and Long Island University have been awarded U.S. patent No. 9,832,998 B2 for a portfolio of compounds that, when applied to polymer surfaces, renders them antiviral, antifungal and antibacterial/antimicrobial.
JaimeLee Rizzo, PhD
“We have developed a compound that, when bonded to a variety of surfaces, kills the H1N1 virus, MRSA, and other pathogens, fungi and bacteria that come into contact with those surfaces, helping to stop the spread of diseases and infections,” says Chemistry Professor JaimeLee Rizzo, PhD, Dyson College of Arts and Sciences, Pace University. She and her fellow researchers, Professor Robert Engel, PhD, Queens College, and Professor Karin Melkonian-Fincher, PhD, of Long Island University, have worked on developing this as part of a portfolio of compounds since 2010.
The patent covers a group of groundbreaking antimicrobial technologies. These compounds have many practical applications across a variety of industries and sectors, such as health care, food, agriculture, construction and the military. The range of surfaces the compound can be bonded to includes many polymer materials, and it could be used on wound dressings, face masks, gowns, linens and countertops found in hospitals, nursing homes, clinics and physicians’ offices; household items, such as sponges, cutting boards and counters; water and air filtration systems; military uniforms; and plastic bottles used in the beverage, health and beauty sectors.
The researchers are working on bringing the compounds to the market in 2018.
The rehabilitation patients at Helen Hayes Hospital in West Haverstraw, New York, were treated to a festive holiday celebration through the generosity of Mayor Robert D’Amelio and the Trustees of the Village of West Haverstraw. The local officials, with the support of over a dozen local businesses and organizations, including the Girl Scouts, resurrected a decades-old tradition of hosting a holiday party for patients and their family members at the specialty physical rehabilitation hospital, which has called the Village home for over 110 years. On Dec. 21, patients who could not return home for the holiday due to their intensive rehab program for life-altering injuries and conditions were treated to a delicious dinner buffet, as well as DJ entertainment and holiday caroling.
West Haverstraw Mayor Robert D’Amelio serves holiday party attendees at Helen Hayes Hospital.
White Plains Hospital unveiled its new facility, encompassing 20,300 square feet of space at the center of the Hospital from floors three to six, at a ribbon-cutting ceremony Nov. 20 on the Hospital’s third floor. This new space was designed by Perkins Eastman architects and complements the Hospital’s ongoing campus modernization and renovation, including the newly expanded Center for Cancer Care, completed in 2016, and the Hospital’s new lobby, completed in 2015. Approximately 200,000 square feet have been renovated or added to the Hospital since 2015.
The new construction project is part of White Plains Hospital’s ongoing modernization, which has included extensive campus renovations, the addition of satellite offices and the acquisition of new specialist practices. With locations across Westchester County, White Plains Hospital’s footprint now extends from New Rochelle to Mount Kisco.
A pilot study, funded by Montefiore Einstein Center for Cancer Care, in partnership with New York Blood Center (NYBC), has successfully demonstrated that white blood cells can be removed, genetically modified and reinserted into cancer patients. This holds potential to fight cancers that standard therapy has failed to treat. The next step is to duplicate this finding in multiple patients.
Montefiore holds the investigational new drug application from the FDA to test the safety and feasibility of the therapy. Working with the National Cancer Institute-designated Albert Einstein Cancer Center, the trial kicked off last summer.
The goal of the pilot study is to enroll five patients and confirm the feasibility and safety of the therapy for solid tumors, such as breast cancer, sarcomas and lung cancer.
Eligibility for the trial is based on highly specific criteria:
- A hereditary marker, found in only 20 percent of Montefiore’s patient population
- Tumors expressing the NY-ESO-1 protein, which is found in 30 percent of all solid tumors
- Advanced metastatic cancer that has failed to respond to standard therapy
It’s all about the blood, so NYBC plays a critical role: Once newly engineered cells are created in the NYBC, patients’ bodies will be prepared for a cell transfusion. This will include one week of chemotherapy at Montefiore to wipe out many of the remaining white blood cells. The clean slate allows the new and improved cells, which are delivered through an IV bag in 20 minutes, to become the first in line to attack the cancer. Immunotherapy is also given to make the re-engineered cells even stronger.
Good Samaritan Hospital has achieved a five-star rating for its performance in Peripheral Vascular Bypass for the second straight year from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals.
The vascular surgery team at Good Samaritan Hospital celebrates its five-star rating from Healthgrades.
Good Samaritan Hospital is the only hospital in lower New York state and northern New Jersey to receive five stars in both 2017 and 2018 for this surgical procedure. Only two other New York hospitals received the highest rating in the new Healthgrades 2018 Report to the Nation.
Nyack Hospital has been awarded a $340,000 Empire State Development grant for the creation of a Transitional Care Unit from New York State’s Mid-Hudson Regional Economic Development Council.
The grant will support the renovation and retrofit of 8,730 square feet of existing space on the Hospital’s fourth floor to create a 16-patient Transitional Care Unit (TCU). The creation of a TCU will allow Nyack Hospital to meet the demand for subacute inpatient services and increase the availability of appropriate post-discharge alternatives in the Hudson Valley region.